It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. As of September 08, 2023, there were 4 analysts who downgraded Repare Therapeutics Inc’s stock and 2 analysts who upgraded over the last month.Īdditionally, you'll want to evaluate Repare Therapeutics Inc’s financial health and valuation. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. But have you ever wondered about what other factors affect a stock's price? Stock prices are primarily based on seller supply and buyer demand. What Caused Repare Therapeutics Inc Stock’s Price to Dip? Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions Year to date, Repare Therapeutics Inc’s stock is down 52.92%. Over the last year, Repare Therapeutics Inc has hit prices as high as $18.68 and as low as $8.02. Repare Therapeutics Inc’s ( RPTX) price is currently up 1.74% so far this month.ĭuring the month of September, Repare Therapeutics Inc’s stock price has reached a high of $10.68 and a low of $9.02. Repare Therapeutics Inc Stock Price History We recommend investors evaluate other financial metrics to understand its overall valuation. Unfortunately, Repare Therapeutics Inc’s P/E ratio is not significant enough to use for stock price evaluation. Currently, there are 42.09 million shares of Repare Therapeutics Inc stock available for purchase. Repare Therapeutics Inc is down 5.43% from its previous closing price of $10.50.ĭuring the last market session, Repare Therapeutics Inc’s stock traded between $9.86 and $10.60. Repare Therapeutics Inc’s Stock Price as of Market CloseĪs of September 11, 2023, 4:00 PM CST, Repare Therapeutics Inc’s stock price was $9.93. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips. Want to learn more about Repare Therapeutics Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Repare Therapeutics Inc. Its RP-6306 is being developed as a highly potent and selective PKMYT1 inhibitor that preferentially kills tumor cells overexpressing CCNE1. The Company’s product pipelines include Camonsertib ATR Inhibitor, RP-6306 PKMYT1 Inhibitor and RP-2119 Pol Inhibitor. Using its SNIPRx platform, the Company is developing its pipeline of SL product candidates, including its lead product candidate, RP-3500, a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase (ATR) for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. The Company uses its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop targeted cancer therapies focused on genomic instability, including deoxyribonucleic acid (DNA) damage repair. is a clinical-stage precision oncology company engaged in developing synthetic lethality (SL) to the discovery and development of novel therapeutics. Stock price momentum as measured by its relative strengthīefore we jump into Repare Therapeutics Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.In this article, we go over a few key elements for understanding Repare Therapeutics Inc’s stock price such as: A smart way to take the guesswork out of knowing when to buy or sell Repare Therapeutics Inc’s stock is to have the right tools and resources as well as a clear monitoring process. One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.īut what if you had the insights to effectively evaluate a company like Repare Therapeutics Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |